Predictors of bone mass in perimenopausal women: A prospective study of clinical data using photon absorptiometry

Charles W. Slemenda, Siu Hui, Christopher Longcope, Henry Wellman, C. Conrad Johnston

Research output: Contribution to journalArticle

257 Citations (Scopus)

Abstract

Study Objective: To determine whether clinically available data on risk factors are adequate to identify perimenopausal women with either low or high bone mass. Design: Cross-sectional observational study of a cohort of perimenopausal women (mean age, 50.8 years). Setting: Community volunteers in a university hospital. Subjects: One hundred twenty-four white volunteers established as perimenopausal by history and serum concentrations of estrogens and follicle-stimulating hormone. Measurements and Main Results: Models were constructed to predict bone mass in the radius, lumbar spine, and hip using risk factors (age, height, weight, calcium and caffeine intake, alcohol and tobacco use, and urinary markers of bone turnover). Although highly significant predictive models were developed for all skeletal sites, none of the models correctly identified more than 70% of women with low bone mass at any site. However, for the radius, a model was constructed that never overestimated bone mass by more than 0.10 g/cm. A small subgroup (7%) with short stature, low body weight, low calcium intake, and who were heavy smokers always had low radial bone mass. Using these models, about 30% of our population could be assessed without bone mass measurements. Predictions for the spine and femur were less efficient, suggesting that direct measurements are required if therapy decisions are to be based on bone mass at these sites. Conclusions: Risk factors for osteoporosis are of limited use in identifying women with low bone mass around the time of menopause. Measurements of bone mass are probably necessary if the risk for osteoporosis is to be the basis for deciding on estrogen replacement therapy.

Original languageEnglish
Pages (from-to)96-101
Number of pages6
JournalAnnals of Internal Medicine
Volume112
Issue number2
StatePublished - Jan 15 1990

Fingerprint

Photon Absorptiometry
Prospective Studies
Bone and Bones
Osteoporosis
Volunteers
Spine
Calcium
Estrogen Replacement Therapy
Bone Remodeling
Follicle Stimulating Hormone
Tobacco Use
Menopause
Caffeine
Femur
Observational Studies
Hip
Estrogens
Cross-Sectional Studies
History
Body Weight

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Predictors of bone mass in perimenopausal women : A prospective study of clinical data using photon absorptiometry. / Slemenda, Charles W.; Hui, Siu; Longcope, Christopher; Wellman, Henry; Johnston, C. Conrad.

In: Annals of Internal Medicine, Vol. 112, No. 2, 15.01.1990, p. 96-101.

Research output: Contribution to journalArticle

Slemenda, Charles W. ; Hui, Siu ; Longcope, Christopher ; Wellman, Henry ; Johnston, C. Conrad. / Predictors of bone mass in perimenopausal women : A prospective study of clinical data using photon absorptiometry. In: Annals of Internal Medicine. 1990 ; Vol. 112, No. 2. pp. 96-101.
@article{60f7e9638d674a78aff5d22aaa40625d,
title = "Predictors of bone mass in perimenopausal women: A prospective study of clinical data using photon absorptiometry",
abstract = "Study Objective: To determine whether clinically available data on risk factors are adequate to identify perimenopausal women with either low or high bone mass. Design: Cross-sectional observational study of a cohort of perimenopausal women (mean age, 50.8 years). Setting: Community volunteers in a university hospital. Subjects: One hundred twenty-four white volunteers established as perimenopausal by history and serum concentrations of estrogens and follicle-stimulating hormone. Measurements and Main Results: Models were constructed to predict bone mass in the radius, lumbar spine, and hip using risk factors (age, height, weight, calcium and caffeine intake, alcohol and tobacco use, and urinary markers of bone turnover). Although highly significant predictive models were developed for all skeletal sites, none of the models correctly identified more than 70{\%} of women with low bone mass at any site. However, for the radius, a model was constructed that never overestimated bone mass by more than 0.10 g/cm. A small subgroup (7{\%}) with short stature, low body weight, low calcium intake, and who were heavy smokers always had low radial bone mass. Using these models, about 30{\%} of our population could be assessed without bone mass measurements. Predictions for the spine and femur were less efficient, suggesting that direct measurements are required if therapy decisions are to be based on bone mass at these sites. Conclusions: Risk factors for osteoporosis are of limited use in identifying women with low bone mass around the time of menopause. Measurements of bone mass are probably necessary if the risk for osteoporosis is to be the basis for deciding on estrogen replacement therapy.",
author = "Slemenda, {Charles W.} and Siu Hui and Christopher Longcope and Henry Wellman and Johnston, {C. Conrad}",
year = "1990",
month = "1",
day = "15",
language = "English",
volume = "112",
pages = "96--101",
journal = "Annals of Internal Medicine",
issn = "0003-4819",
publisher = "American College of Physicians",
number = "2",

}

TY - JOUR

T1 - Predictors of bone mass in perimenopausal women

T2 - A prospective study of clinical data using photon absorptiometry

AU - Slemenda, Charles W.

AU - Hui, Siu

AU - Longcope, Christopher

AU - Wellman, Henry

AU - Johnston, C. Conrad

PY - 1990/1/15

Y1 - 1990/1/15

N2 - Study Objective: To determine whether clinically available data on risk factors are adequate to identify perimenopausal women with either low or high bone mass. Design: Cross-sectional observational study of a cohort of perimenopausal women (mean age, 50.8 years). Setting: Community volunteers in a university hospital. Subjects: One hundred twenty-four white volunteers established as perimenopausal by history and serum concentrations of estrogens and follicle-stimulating hormone. Measurements and Main Results: Models were constructed to predict bone mass in the radius, lumbar spine, and hip using risk factors (age, height, weight, calcium and caffeine intake, alcohol and tobacco use, and urinary markers of bone turnover). Although highly significant predictive models were developed for all skeletal sites, none of the models correctly identified more than 70% of women with low bone mass at any site. However, for the radius, a model was constructed that never overestimated bone mass by more than 0.10 g/cm. A small subgroup (7%) with short stature, low body weight, low calcium intake, and who were heavy smokers always had low radial bone mass. Using these models, about 30% of our population could be assessed without bone mass measurements. Predictions for the spine and femur were less efficient, suggesting that direct measurements are required if therapy decisions are to be based on bone mass at these sites. Conclusions: Risk factors for osteoporosis are of limited use in identifying women with low bone mass around the time of menopause. Measurements of bone mass are probably necessary if the risk for osteoporosis is to be the basis for deciding on estrogen replacement therapy.

AB - Study Objective: To determine whether clinically available data on risk factors are adequate to identify perimenopausal women with either low or high bone mass. Design: Cross-sectional observational study of a cohort of perimenopausal women (mean age, 50.8 years). Setting: Community volunteers in a university hospital. Subjects: One hundred twenty-four white volunteers established as perimenopausal by history and serum concentrations of estrogens and follicle-stimulating hormone. Measurements and Main Results: Models were constructed to predict bone mass in the radius, lumbar spine, and hip using risk factors (age, height, weight, calcium and caffeine intake, alcohol and tobacco use, and urinary markers of bone turnover). Although highly significant predictive models were developed for all skeletal sites, none of the models correctly identified more than 70% of women with low bone mass at any site. However, for the radius, a model was constructed that never overestimated bone mass by more than 0.10 g/cm. A small subgroup (7%) with short stature, low body weight, low calcium intake, and who were heavy smokers always had low radial bone mass. Using these models, about 30% of our population could be assessed without bone mass measurements. Predictions for the spine and femur were less efficient, suggesting that direct measurements are required if therapy decisions are to be based on bone mass at these sites. Conclusions: Risk factors for osteoporosis are of limited use in identifying women with low bone mass around the time of menopause. Measurements of bone mass are probably necessary if the risk for osteoporosis is to be the basis for deciding on estrogen replacement therapy.

UR - http://www.scopus.com/inward/record.url?scp=0025141775&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025141775&partnerID=8YFLogxK

M3 - Article

C2 - 2294827

AN - SCOPUS:0025141775

VL - 112

SP - 96

EP - 101

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

SN - 0003-4819

IS - 2

ER -